Literature DB >> 9464246

Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 3'-untranslated region.

Q Gou1, C H Liu, P Ben-Av, T Hla.   

Abstract

The immediate early gene cyclooxygenase-2 (Cox-2), which encodes the inducible prostaglandin synthase enzyme, is regulated at the level of post-transcriptional mRNA turnover. In this study, the functional role of the 3'-untranslated region (3'-UTR) of the human Cox-2 gene was characterized. Deletion of the distal region of the 3'-UTR strongly inhibited basal mRNA turnover, suggesting that this region contains mRNA instability determinants. However, deletion of the proximal highly-conserved region (CR1: 6082-6198) resulted in increased basal turnover, indicating that it determines mRNA stability. All of the 3'-UTR constructs conferred IL-1-induced stabilization but not dexamethasone-induced down-regulation. Thus, distinct regions of the 3'-UTR of the Cox-2 transcript are involved in the regulation of basal and cytokine-induced mRNA metabolism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9464246     DOI: 10.1006/bbrc.1997.7994

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Specific trans-acting proteins interact with auxiliary RNA polyadenylation elements in the COX-2 3'-UTR.

Authors:  Tyra Hall-Pogar; Songchun Liang; Lisa K Hague; Carol S Lutz
Journal:  RNA       Date:  2007-05-16       Impact factor: 4.942

2.  Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38.

Authors:  M Lasa; M Brook; J Saklatvala; A R Clark
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

3.  Pathophysiological basis of acute inflammatory hyperaemia in the rat knee: roles of cyclo-oxygenase-1 and -2.

Authors:  Colin G Egan; John C Lockhart; William R Ferrell; Suzanne M Day; John S McLean
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

4.  Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice.

Authors:  C B Keerthisingam; R G Jenkins; N K Harrison; N A Hernandez-Rodriguez; H Booth; G J Laurent; S L Hart; M L Foster; R J McAnulty
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

5.  Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle.

Authors:  David L Allen; Amanda S Loh
Journal:  Am J Physiol Cell Physiol       Date:  2010-10-27       Impact factor: 4.249

6.  Loss of 15-hydroxyprostaglandin dehydrogenase increases prostaglandin E2 in pancreatic tumors.

Authors:  Hung Pham; Monica Chen; Aihua Li; Jonathan King; Eliane Angst; David W Dawson; Jenny Park; Howard A Reber; O Joe Hines; Guido Eibl
Journal:  Pancreas       Date:  2010-04       Impact factor: 3.327

7.  Imaging cyclooxygenase-2 (Cox-2) gene expression in living animals with a luciferase knock-in reporter gene.

Authors:  Tomo-O Ishikawa; Naveen K Jain; Makoto M Taketo; Harvey R Herschman
Journal:  Mol Imaging Biol       Date:  2006 May-Jun       Impact factor: 3.488

8.  Alternative polyadenylation of cyclooxygenase-2.

Authors:  Tyra Hall-Pogar; Haibo Zhang; Bin Tian; Carol S Lutz
Journal:  Nucleic Acids Res       Date:  2005-05-04       Impact factor: 16.971

Review 9.  COX-2 and the vasculature: angel or evil?

Authors:  Chiara Cuccurullo; Andrea Mezzetti; Francesco Cipollone
Journal:  Curr Hypertens Rep       Date:  2007-03       Impact factor: 4.592

10.  Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study.

Authors:  Jung Min Park; Jin Eun Choi; Myung Hwa Chae; Won Kee Lee; Sung Ick Cha; Ji-Woong Son; Chang Ho Kim; Sin Kam; Young Mo Kang; Tae Hoon Jung; Jae Yong Park
Journal:  BMC Cancer       Date:  2006-03-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.